243 related articles for article (PubMed ID: 10676640)
1. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
2. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone selectively inhibits WY14,643-induced cell proliferation and not peroxisome proliferation in mice.
Lawrence JW; Wollenberg GK; Frank JD; DeLuca JG
Toxicol Appl Pharmacol; 2001 Jan; 170(2):113-23. PubMed ID: 11162775
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
[TBL] [Abstract][Full Text] [Related]
8. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and differentiation patterns of the oval cell lines OC/CDE 6 and OC/CDE 22 derived from the livers of carcinogen-treated rats.
Radaeva S; Steinberg P
Cancer Res; 1995 Mar; 55(5):1028-38. PubMed ID: 7532542
[TBL] [Abstract][Full Text] [Related]
10. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
11. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
Weglarz TC; Sandgren EP
Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
[TBL] [Abstract][Full Text] [Related]
12. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
[TBL] [Abstract][Full Text] [Related]
13. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha.
Roberts RA; James NH; Hasmall SC; Holden PR; Lambe K; Macdonald N; West D; Woodyatt NJ; Whitcome D
Toxicol Lett; 2000 Mar; 112-113():49-57. PubMed ID: 10720712
[TBL] [Abstract][Full Text] [Related]
16. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
[TBL] [Abstract][Full Text] [Related]
18. Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats.
Pack R; Heck R; Dienes HP; Oesch F; Steinberg P
Exp Cell Res; 1993 Feb; 204(2):198-209. PubMed ID: 7679995
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA
Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
